SALGOT; Stroke Arm Longitudinal Study at the University of GOThenburg (SALGOT)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01115348 |
|
Recruitment Status : Unknown
Verified February 2017 by Göteborg University.
Recruitment status was: Active, not recruiting
First Posted : May 4, 2010
Last Update Posted : February 2, 2017
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Stroke is the most common cause for motor disability in the grown-up population in the Western world. In Sweden > 80 % are above 65 years of age at onset (1).Areas in the brain, controlling the movement in the upper extremity (UE) are often damaged at a stroke, which leads to impaired function. This impairment of the UE often leads to limitations in activities of daily living and reductions in the level of social activities; therefore, interventions that will improve function are needed to reduce the consequences for the person living with stroke. The time course of recovery of the UE is not clear and therefore the optimal timing of the intervention for the person and its content (ways of intervention) uncertain.
The investigators have developed objective assessments of motor performance with new technology (kinematic analysis and virtual reality with haptics). Since having an impaired UE often results in reduced capacity in daily living and social activities, this might lead to decreased participation. To complement the traditional focus on body function, there is a need for assessments of the person's activity level and participation, as well as self-perceived function.
The results from this study will lay the ground for an intervention study focusing on improved function in the upper extremity.
| Condition or disease |
|---|
| Stroke Motor Activity |
Tools to objectively assess upper extremity function and activity Grippit: The handgrip force will be recorded, both the peak maximum grip force and the mean value of the ten-second sustained grip for the right hand Kinematics: An optoelectronic system is used for the three-dimensional motion analysis. This system includes an advanced optoelectronic camera system that produces clean and accurate 3D data. Ball shaped markers are positioned on the body, and reflect infrared light from camera flashes. Data analysis itself is performed with special software. The drinking task test is performed with the person sitting in a standardized manner ARAT (Action research Arm Test) is a performance test for UE function and dexterity.
VR The user observes a 3D image displayed above the tabletop using stereographic shuttered glasses. The user is able to reach into a virtual space and interact with 3-dimensional objects, with a haptic device, which creates the illusion of manipulating virtual objects.
Tool to assess self perceived function and activity ABILHAND is a questionnaire aiming to measure manual ability in chronic stroke. It is interview based and focused on perceived difficulty in everyday activities and contains unimanual and bimanual activities.
Stroke Impact Scale (SIS) is a scale where the person replies on perceptions regarding life after the stroke..
Impact on participation and autonomy (IPA-E); is an instrument where the person estimates perceived handicap and autonomy for persons living in the community
| Study Type : | Observational |
| Estimated Enrollment : | 120 participants |
| Observational Model: | Cohort |
| Time Perspective: | Prospective |
| Official Title: | Stroke Arm Longitudinal Study at the University of Gothenburg;SALGOT |
| Study Start Date : | March 2009 |
| Actual Primary Completion Date : | December 2011 |
| Estimated Study Completion Date : | December 2017 |
- Upper extremity function [ Time Frame: 12 months ]
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- first occurrence of a stroke will be included and followed longitudinally for one year after the stroke.
- Reduced UE function on the M-MAS UAS-95 on day 2 after stroke > 18 years of age
Exclusion Criteria:
- Other disease/injury that affect upper extremity function
- Life expectancy less than 12 months (study time)
- Not able to communicate in Swedish
- Not living in the catchment area of the hospital
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01115348
| Sweden | |
| Stroke Unit, Sahlgrenska University Hospital | |
| Gothenburg, Sweden | |
| Principal Investigator: | Katharina Stibrant Sunnerhagen, MD, PhD | Göteborg University |
| Responsible Party: | Göteborg University |
| ClinicalTrials.gov Identifier: | NCT01115348 |
| Other Study ID Numbers: |
SALGOT |
| First Posted: | May 4, 2010 Key Record Dates |
| Last Update Posted: | February 2, 2017 |
| Last Verified: | February 2017 |
|
Stroke Cerebrovascular Disorders Brain Diseases Central Nervous System Diseases |
Nervous System Diseases Vascular Diseases Cardiovascular Diseases |